Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

14 September 2026

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

14 September 2026

Northern Trust Corporation (NTRS) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

14 September 2026

Galderma: Launch Investment Is Becoming An Earnings Engine (OTCMKTS:GALDY)

14 September 2026

'The water turned brown and we all started vomiting' – inside UK's toxic sea summer

14 September 2026
Facebook X (Twitter) Instagram
Business Monday, Sep 14
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript
News

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk14 September 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

Operator

Good morning, ladies and gentlemen. Welcome to the Cellectis Live conference call, English session. [Operator Instructions]

This call is being recorded on Monday, September 14, 2026. I would now like to turn the conference over to Arthur Stril, CFO and CBO. Please go ahead.

Arthur Stril
CFO & Chief Business Officer

Good morning, everyone, and thank you for joining us. I am Arthur Stril, Cellectis’ Chief Financial Officer and Chief Business Officer. Before we begin, please note that this presentation contains forward-looking statements within the meaning of applicable securities laws, including the Private Securities Litigation Reform Act of 1995, including statements regarding our strategy, development programs, financial conditions and potential future prospects. These forward-looking statements are based on our current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.

For a discussion of these risks and uncertainties, please refer to our filings within the U.S. Securities and Exchange Commission, including, without limitation, our 6-Ks, annual report on Form 20-F, our press releases and annual financial report prepared in French. Except as required by law, we undertake no obligation to publicly update or revise any forward-looking statements contained in this

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Northern Trust Corporation (NTRS) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Galderma: Launch Investment Is Becoming An Earnings Engine (OTCMKTS:GALDY)

'The water turned brown and we all started vomiting' – inside UK's toxic sea summer

T1 Energy: G2_Austin Can Change Profits From 2027 (NYSE:TE)

Marathon Petroleum: Further Upside With Refining Boom Set To Last Through 2027 (NYSE:MPC)

Wall Street Breakfast Podcast: Oil’s New Chokepoint

Rivian: Financial Turnaround Makes This Less A Clear Sell (NASDAQ:RIVN)

‘My skin felt like it was concrete and I was trapped in my home for five months after using eczema cream'

Editors Picks

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

14 September 2026

Northern Trust Corporation (NTRS) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

14 September 2026

Galderma: Launch Investment Is Becoming An Earnings Engine (OTCMKTS:GALDY)

14 September 2026

'The water turned brown and we all started vomiting' – inside UK's toxic sea summer

14 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

T1 Energy: G2_Austin Can Change Profits From 2027 (NYSE:TE)

14 September 2026

Marathon Petroleum: Further Upside With Refining Boom Set To Last Through 2027 (NYSE:MPC)

14 September 2026
Tyrur Holdings Managed Accounts Review: Is the Fully Automated Portfolio Worth It?

Tyrur Holdings Managed Accounts Review: Is the Fully Automated Portfolio Worth It?

14 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.